Abbvie INC (ABBV) Shares Declined While Stephens INC Decreased Its Stake

April 17, 2018 - By Sheila Anderson

AbbVie Inc. (NYSE:ABBV) Corporate LogoBig Money Sentiment decreased to 0.8 in Q4 2017. It has change of 0.05, from 2017Q3’s 0.85. The ratio worsened due to ABBV positioning: 42 sold and 695 reduced. 139 funds bought holdings and 448 increased holdings. Investors holded 1.06 billion in 2017Q3 but now own 1.06 billion shares or 0.35% more. Oakworth Capital Inc holds 0.21% or 9,231 shs in its capital. Commonwealth Comml Bank Of Aus, a Australia-based fund reported 122,911 shs. Public Sector Pension Inv Board owns 85,435 shs for 0.05% of their capital. Wealth Architects Ltd Liability Co reported 0.2% stake. Prtnrs Limited Oh Adv accumulated 0.42% or 5,850 shs. Northstar Inv Limited Liability Co accumulated 11,843 shs or 0.21% of the stock. Osborne Prns Cap Mngmt Ltd Liability Corporation has invested 0.62% in AbbVie Inc. (NYSE:ABBV). Paradigm Asset Mgmt Company Limited Company holds 23,900 shs. Balasa Dinverno And Foltz Limited Company reported 17,270 shs. Los Angeles Capital Mngmt Equity Rech Inc reported 344,001 shs. Mai Capital Mngmt accumulated 44,915 shs. Clear Harbor Asset Mngmt, New York-based fund reported 9,840 shs. Athena Capital Advsrs Ltd Liability Corp reported 3,815 shs stake. Horseman Capital Mngmt Ltd accumulated 21,000 shs. Investment House Llc has invested 1.2% in AbbVie Inc. (NYSE:ABBV).

ABBV registered $49.35 million net activity with 0 buys and 12 selling transactions since October 30, 2017. $2.95M worth of AbbVie Inc. (NYSE:ABBV) shs were sold by Schumacher Laura J. $512,853 worth of AbbVie Inc. (NYSE:ABBV) was sold by Michael Robert A.. $2.15 million worth of AbbVie Inc. (NYSE:ABBV) shs were sold by RICHMOND TIMOTHY J.. Gosebruch Henry O sold $1.66M worth of AbbVie Inc. (NYSE:ABBV) on Monday, October 30. CHASE WILLIAM J sold $8.31 million worth of stock or 70,928 shs. $976,084 worth of AbbVie Inc. (NYSE:ABBV) was sold by GONZALEZ RICHARD A on Wednesday, February 28.

In Abbvie Inc (ABBV) was reduced the stake owned by Stephens Inc. The decrease is 18.67% according to 2017Q4 SEC filling. 59,411 shares were sold by Stephens Inc as the company’s stock declined 6.31% with the market. At the end of 2017Q4, the 258,876 shares of the major pharmaceuticals company held by the institutional investor were valued at $25.04 million, down from 318,287 at the end of the previous reported quarter. Abbvie Inc has $146.93B MC. ABBV reached $92.6 on during the last trading session after $0.77 change.AbbVie Inc. has volume of 3.92M shares. Since April 17, 2017 ABBV has risen 39.20% and is uptrending. ABBV outperformed the S&P500 by 27.65%.

About $6.58B and $2.67B US Long portfolio Stephens Inc manages. It increased its stake in Johnson Ctls Intl Plc by 111,272 shares to 186,935 shares, valued at $7.12M in 2017Q4, according to the filing. For a total of 197,670 shares it increased its holding in National Oilwell Varco Inc (NYSE:NOV) by 97,530 shares in the quarter, and has risen its stake in Ishares Tr (IYR).

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26. They expect $1.78 EPS, up 39.06 % or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.82B for 13.01 P/E if the $1.78 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27 % EPS growth.

AbbVie Inc. (NYSE:ABBV) Ratings Coverage

In total 13 analysts cover AbbVie (NYSE:ABBV). “Buy” rating has 6, “Sell” are 1, while 6 are “Hold”. 46% are bullish. With $15700 highest and $80 lowest [Target] AbbVie has $123.91 average [Target] or 33.81% above the current ($92.6) price. 25 are the (NYSE:ABBV)’s analyst reports since October 30, 2017 according to StockzIntelligence Inc. On Monday, March 26 the stock has “Hold” rating by Bank of America. The stock rating was maintained by BMO Capital Markets with “Underperform” on Friday, March 23. On Thursday, March 22 the firm earned “Hold” rating by Leerink Swann. On Thursday, March 22 SunTrust maintained AbbVie Inc. (NYSE:ABBV) rating. SunTrust has “Buy” rating and $15700 target. On Tuesday, January 30 BMO Capital Markets downgraded the shares of ABBV in report to “Underperform” rating. On Monday, February 26 the stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given by Jefferies. On Friday, March 23 the company was maintained by Jefferies. On Tuesday, January 30 the stock of AbbVie Inc. (NYSE:ABBV) earned “Equal-Weight” rating by Morgan Stanley. On Thursday, January 4 the firm has “Buy” rating by Jefferies given. On Monday, October 30 the stock of AbbVie Inc. (NYSE:ABBV) has “Outperform” rating given by Leerink Swann.

AbbVie Inc. (NYSE:ABBV) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: